At Dana-Farber/Boston Children's Cancer and Blood Disorders Center, our clinicians collaborate with teams of expert subspecialists to provide truly comprehensive care for our patients. Dana-Farber/Boston Children's is the only pediatric cancer and blood disorders center in the country that integrates the specialized resources of a top pediatric hospital — Boston Children's Hospital — with those of a world-renowned cancer center — Dana-Farber Cancer Institute. No other center of its kind can offer your child our breadth of expertise.
Our history of research and innovation has resulted in many of the diagnostic and therapeutic techniques currently used around the world to treat cancer and blood disorders. Today, we continue to stand among the world's leaders in many innovative approaches, such as CAR T-cell therapy, gene therapy, immunotherapy, and MIBG therapy (for neuroblastoma).
Utilizing proven treatment protocols and innovative therapies, Dana-Farber/Boston Children's treats blood disorders in children and young adults and over 100 forms of cancer, including brain tumors, solid tumors (such as osteosarcoma and neuroblastoma), and malignant blood cancers (such as leukemia, lymphoma, and histiocytosis).
At Dana-Farber/Boston Children's, we care for children with cancer and blood disorders in our specialized treatment centers and specialty programs that are focused on specific cancer and blood disorder types. Our teams of specialists work closely to offer patients the latest therapies, including access to clinical trials.
Our multidisciplinary approach to care ensures that your child will receive the combination of treatments for their particular diagnosis and geared to their specific needs. In addition to personalized treatments, our clinical services also provide special expertise in the social, emotional, and psychological aspects of caring for children with cancer and blood disorders.
Through the Global Health Initiative, Dana-Farber/Boston Children's brings together faculty, fellows, nurses, social workers, psychologists, health educators, and managers who are involved in international projects on childhood cancer to improve outcomes and survival rates for children with cancer and blood disorders worldwide.